The global nasal drug delivery systems market revenue is expected to register a moderate CAGR over the forecast period. Rising patient preference towards use nasal drug delivery, owing to its several advantages such as better efficacy, easy administration, and self-medication are major factors expected to drive the growth of the market over the forecast period.

Increasing number of cases of respiratory diseases across the globe is a major factors expected to support growth of the market over the forecast period. In addition, increasing number of product approvals for nasal drug delivery systems is other factor expected to boost the growth of the global nasal drug delivery systems market over the forecast period.

The global nasal drug delivery systems market report has been segmented on the basis of dosage form, system type, therapeutic application, and region.

Based on system type, the global nasal drug delivery systems market is segmented based on multi-dose, bi-dose, and unit dose. The multi-dose drug delivery systems account for major revenue share of the market.

Based on therapeutic application, the global nasal drug delivery systems market is segmented based on allergic and non-allergic rhinitis, nasal congestion, and vaccinations. The allergic and non-allergic segment is expected to register highest growth rate over the forecast period.

Request for the Sample Report Here: https://marketresearch.biz/report/nasal-drug-delivery-systems-market/request-sample/

Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major revenue share and is expected to maintain its dominance over the forecast period. Presence of significant number of players in the market coupled with increasing number of product approvals are major factors expected to boost growth of the market in the region over the forecast. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like China and India is expected to support the growth of the market in Asia Pacific region, owing to the increasing prevalence of respiratory diseases in these countries.

Some prominent players in the global nasal drug delivery systems market are Merck & Co., Inc., Novartis AG, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Pfizer Inc., Astrazeneca PLC Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, AptarGroup, Inc., and Aegis Therapeutics LLC.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: